USD 0.33
(-23.27%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -690.85 Thousand USD | -250.62% |
2022 | 458.66 Thousand USD | 86153.85% |
2021 | -533.00 USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2023 Q1 | 52.12 Thousand USD | -89.01% |
2023 FY | -690.85 Thousand USD | -250.62% |
2023 Q4 | -955.48 Thousand USD | -852.23% |
2023 Q3 | 127.02 Thousand USD | 48.57% |
2023 Q2 | 85.49 Thousand USD | 64.04% |
2022 Q2 | -28.53 Thousand USD | 81.41% |
2022 Q1 | -153.49 Thousand USD | 0.0% |
2022 FY | 458.66 Thousand USD | 86153.85% |
2022 Q4 | 474.36 Thousand USD | 127.71% |
2022 Q3 | 208.32 Thousand USD | 830.04% |
2021 Q3 | -80.00 USD | 96.02% |
2021 Q2 | -2010.00 USD | 0.0% |
2021 FY | -533.00 USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Alignment Healthcare, Inc. | -148.01 Million USD | 99.533% |
Clover Health Investments, Corp. | -213.36 Million USD | 99.676% |
Marpai, Inc. | -28.75 Million USD | 97.597% |